Alternatively, HO-1 appears to counteract tumor growth in non-small cell lung carcinoma [40] and in breast cancer it suppresses the invasive capacity of cells via MMP9 down-regulation [41]. This evidence concerns the gene MMP9 and non-small cell lung carcinoma.